In vitro and in vivo activity of ceftazidime/avibactam and aztreonam alone or in combination against mcr-9, serine- and metallo-β-lactamases–co-producing carbapenem-resistant Enterobacter cloacae complex
European Journal of Clinical Microbiology & Infectious Diseases · 2024
DOI: 10.1007/s10096-024-04841-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Wengang Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Aztreonam, Drug Combinations, Azabicyclo Compounds, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Joint project of Chongqing Health Commission and Science and Technology Bureau, Yongchuan Natural Science Foundation, Talent introduction project of Yongchuan Hospital of Chongqing Medical University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China.
- Department of Pathogenic Biology, Jiamusi University School of Basic Medicine, Jiamusi, China.
- Department of Clinical Laboratory, The First Affiliated Hospital of Jiamusi University, Jiamusi, China.
- Department of Life Science and Technology, Mudanjiang Normal University, Mudanjiang, China. mdjlcj07@163.com.
- Department of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China. jmszxl123@163.com.
Förderung
- Joint project of Chongqing Health Commission and Science and Technology Bureau
- Yongchuan Natural Science Foundation
- Talent introduction project of Yongchuan Hospital of Chongqing Medical University
- Program for Youth Innovation in Future Medicine, Chongqing Medical University
Zitieren
APA
Li, W., Zhang, J., Fu, Y., Wang, J., Liu, L., Long, W., Yu, K., Li, X., Wei, C., Liang, X., Wang, J., Li, C., & Zhang, X. (2024). In vitro and in vivo activity of ceftazidime/avibactam and aztreonam alone or in combination against mcr-9, serine- and metallo-β-lactamases–co-producing carbapenem-resistant Enterobacter cloacae complex. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04841-8
Vancouver
Li W, Zhang J, Fu Y, Wang J, Liu L, Long W, et al. In vitro and in vivo activity of ceftazidime/avibactam and aztreonam alone or in combination against mcr-9, serine- and metallo-β-lactamases–co-producing carbapenem-resistant Enterobacter cloacae complex. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04841-8
BibTeX
@article{Li2024,
author = {Li, Wengang and Zhang, Jisheng and Fu, Yanjun and Wang, Jianmin and Liu, Longjin and Long, Wenzhang and Yu, Kaixin and Li, Xinhui and Wei, Chunli and Liang, Xushan and Wang, Jin and Li, Chunjiang and Zhang, Xiaoli},
title = {In vitro and in vivo activity of ceftazidime/avibactam and aztreonam alone or in combination against mcr-9, serine- and metallo-β-lactamases–co-producing carbapenem-resistant Enterobacter cloacae complex},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2024},
doi = {10.1007/s10096-024-04841-8}
}
EUVIMED